These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3824698)

  • 1. Influence of thromboxane A2 inhibition on the development of hydronephrotic atrophy.
    Huland H; Brenger B; Gonnermann D; Schäfer H
    Urol Int; 1986; 41(6):422-5. PubMed ID: 3824698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversibility of preglomerular active vasoconstriction in the first weeks after complete unilateral ureteral obstruction by inhibition of prostaglandin synthesis.
    Huland H; Gonnermann D; Leichtweiss HP; Dietrich-Hennings R
    J Urol; 1983 Oct; 130(4):820-4. PubMed ID: 6887428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of hydronephrotic atrophy: the cause and role of active preglomerular vasoconstriction.
    Huland H; Gonnermann D
    Urol Int; 1983; 38(4):193-8. PubMed ID: 6879865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of thromboxane to renal resistance changes in the isolated perfused hydronephrotic rabbit kidney.
    Kawasaki A; Needleman P
    Circ Res; 1982 Apr; 50(4):486-90. PubMed ID: 7039861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of thromboxane inhibition on tubuloglomerular feedback in hydronephrotic kidneys.
    Morsing P; Stenberg A; Persson AE
    Kidney Int; 1989 Sep; 36(3):447-52. PubMed ID: 2593488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ureteral obstruction on renal cortical blood flow.
    Huland H; Leichtweiss HP; Schröder H; Jeschkies R
    Urol Int; 1982; 37(3):213-9. PubMed ID: 7123711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for two distinct and functionally important sites of enhanced thromboxane production after bilateral ureteral obstruction in the rat.
    Harris KP; Yanagisawa H; Schreiner GF; Klahr S
    Clin Sci (Lond); 1991 Aug; 81(2):209-13. PubMed ID: 1653665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thromboxane inhibition on renal blood flow in dogs with complete unilateral ureteral obstruction.
    Loo MH; Marion DN; Vaughan ED; Felsen D; Albanese CT
    J Urol; 1986 Dec; 136(6):1343-7. PubMed ID: 3464764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydronephrotic atrophy after stable mild or severe partial ureteral obstruction: natural history and recovery after relief of obstruction.
    Gonnermann D; Huland H; Schweiker U; Oesterreich FU
    J Urol; 1990 Jan; 143(1):199-203. PubMed ID: 2294253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphogenesis of nephropathy with partial ureteral obstruction and vesicoureteral reflux.
    Sommer JT; Stephens FD
    J Urol; 1981 Jan; 125(1):67-72. PubMed ID: 7463588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of inflammatory cells associated with exaggerated arachidonic acid metabolism in renal injury.
    Jonas PE; DeSchryver K; Okegawa T; Leahy K; Needleman P
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():65-73. PubMed ID: 6221640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue inhibitor of metalloproteinase-3 plays important roles in the kidney following unilateral ureteral obstruction.
    Kawamoto H; Yasuda O; Suzuki T; Ozaki T; Yotsui T; Higuchi M; Rakugi H; Fukuo K; Ogihara T; Maeda N
    Hypertens Res; 2006 Apr; 29(4):285-94. PubMed ID: 16778336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nitric oxide deficiency in the development of hypertension in hydronephrotic animals.
    Carlström M; Brown RD; Edlund J; Sällström J; Larsson E; Teerlink T; Palm F; Wåhlin N; Persson AE
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F362-70. PubMed ID: 18032548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic and cellular alterations underlying the exaggerated renal prostaglandin and thromboxane synthesis in ureter obstruction in rabbits. Inflammatory response involving fibroblasts and mononuclear cells.
    Okegawa T; Jonas PE; DeSchryver K; Kawasaki A; Needleman P
    J Clin Invest; 1983 Jan; 71(1):81-90. PubMed ID: 6848562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane synthetase inhibition improves function of hydronephrotic rat kidneys.
    Klotman PE; Smith SR; Volpp BD; Coffman TM; Yarger WE
    Am J Physiol; 1986 Feb; 250(2 Pt 2):F282-7. PubMed ID: 3456211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 24-hour ureteral obstruction on subsequent ischemic damage in rat kidney.
    Yokoyama M; Seike H; Ochi K; Takeuchi M
    Urol Int; 1983; 38(5):263-6. PubMed ID: 6636368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thromboxane A2 synthesis inhibitor (OKY-046) on total liver ischemia in rats.
    Kobayashi T; Esato K; Morita N; Noshima NS
    Int Surg; 1996; 81(2):115-8. PubMed ID: 8912073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental obstructive hydronephrosis in newborn rats. II. Long-term effects on renal blood flow distribution.
    Josephson S; Wolgast M; Ojteg G
    Scand J Urol Nephrol; 1982; 16(2):179-85. PubMed ID: 7123170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydronephrosis causes salt-sensitive hypertension and impaired renal concentrating ability in mice.
    Carlström M; Sällström J; Skøtt O; Larsson E; Wåhlin N; Persson AE
    Acta Physiol (Oxf); 2007 Mar; 189(3):293-301. PubMed ID: 17305709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubuloglomerular feedback in obstructive uropathy.
    Morsing P; Persson AE
    Kidney Int Suppl; 1991 Jun; 32():S110-4. PubMed ID: 1881032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.